Life Sciences Horizons Brochure 2025 - Flipbook - Page 28
.
2025 Horizons Life Sciences and Health Care
Future of Energy & ESG
27
4
Click on a section to take you to the relevant page
28
Navigating the energy transition: Challenges
and opportunities in life sciences
29
EU CS3D brings rising ESG compliance and
litigation challenges
30
Sustainability and digital transformation to
reshape global supply chains
31
Radioactive material licensing compliance
concerns
32
EmpCo directive restricts environmental
claims in the EU
33
EU planning for green claims directive
34
Navigating evolving U.S. national security laws:
Implications for biologics companies
35
Manufacturers beware: Trump “America First
Trade Policy” could change the “Buy American”
landscape in 2025 for drug, biologic, and
medical device contracts
36
Anti-corruption risks facing companies in the
Middle East
